What is the ticker symbol for Adagio Therapeutics?

Adagio Therapeutics trades under the ticker ADGI on NASDAQ.

What sector does Adagio Therapeutics operate in?

Adagio Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ADGI in a portfolio?

PortView shows ADGI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Adagio Therapeutics (ADGI) Stock Analysis

NASDAQHealthcareBiotechnology

$4.64+0.87%

1-year price historyRange $2.54 – $47.04

Track ADGI in your portfolio for free · Portfolio tracker

What Adagio Therapeutics does

Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.

Key metrics

Market cap

$505.68M

P/E (TTM)

-1.76

EPS (TTM)

$-2.63

Beta

0.00

Dividend yield

0.00%

Revenue / share

$0.18

ETFs linked to ADGI

Broad-market and Healthcare sector ETFs an investor holding Adagio Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ADGI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ADGI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Adagio Therapeutics?: Adagio Therapeutics trades under the ticker ADGI on NASDAQ.
Which exchange is ADGI listed on?: ADGI is listed on NASDAQ.
What sector does Adagio Therapeutics operate in?: Adagio Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ADGI in a portfolio?: PortView shows ADGI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.